BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31842975)

  • 1. DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways.
    Noreen F; Küng T; Tornillo L; Parker H; Silva M; Weis S; Marra G; Rad R; Truninger K; Schär P
    Clin Epigenetics; 2019 Dec; 11(1):196. PubMed ID: 31842975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.
    Hinoue T; Weisenberger DJ; Pan F; Campan M; Kim M; Young J; Whitehall VL; Leggett BA; Laird PW
    PLoS One; 2009 Dec; 4(12):e8357. PubMed ID: 20027224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.
    Samowitz WS; Albertsen H; Sweeney C; Herrick J; Caan BJ; Anderson KE; Wolff RK; Slattery ML
    J Natl Cancer Inst; 2006 Dec; 98(23):1731-8. PubMed ID: 17148775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf
    Tao Y; Kang B; Petkovich DA; Bhandari YR; In J; Stein-O'Brien G; Kong X; Xie W; Zachos N; Maegawa S; Vaidya H; Brown S; Chiu Yen RW; Shao X; Thakor J; Lu Z; Cai Y; Zhang Y; Mallona I; Peinado MA; Zahnow CA; Ahuja N; Fertig E; Issa JP; Baylin SB; Easwaran H
    Cancer Cell; 2019 Feb; 35(2):315-328.e6. PubMed ID: 30753828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
    Kim YH; Kakar S; Cun L; Deng G; Kim YS
    Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.
    Kriegl L; Neumann J; Vieth M; Greten FR; Reu S; Jung A; Kirchner T
    Mod Pathol; 2011 Jul; 24(7):1015-22. PubMed ID: 21423154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
    Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Meyerhardt JA; Loda M; Giovannucci EL; Fuchs CS
    Gut; 2009 Jan; 58(1):90-6. PubMed ID: 18832519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
    Slattery ML; Curtin K; Sweeney C; Levin TR; Potter J; Wolff RK; Albertsen H; Samowitz WS
    Int J Cancer; 2007 Feb; 120(3):656-63. PubMed ID: 17096326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype.
    Tricarico R; Madzo J; Scher G; Cohen M; Jelinek J; Maegawa S; Nagarathinam R; Scher C; Chang WC; Nicolas E; Slifker M; Zhou Y; Devarajan K; Cai KQ; Kwok T; Nakajima P; Xu J; Mancuso P; Doneddu V; Bagella L; Williams R; Balachandran S; Maskalenko N; Campbell K; Ma X; Cañadas I; Viana-Errasti J; Moreno V; Valle L; Grivennikov S; Peshkova I; Kurilenko N; Mazitova A; Koltsova E; Lee H; Walsh M; Duttweiler R; Whetstine JR; Yen TJ; Issa JP; Bellacosa A
    Gastroenterology; 2023 May; 164(6):921-936.e1. PubMed ID: 36764492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proto CpG island methylator phenotype of sessile serrated adenomas/polyps.
    Parker HR; Orjuela S; Martinho Oliveira A; Cereatti F; Sauter M; Heinrich H; Tanzi G; Weber A; Komminoth P; Vavricka S; Albanese L; Buffoli F; Robinson MD; Marra G
    Epigenetics; 2018; 13(10-11):1088-1105. PubMed ID: 30398409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.
    Bae JM; Kim JH; Kang GH
    Histol Histopathol; 2013 May; 28(5):585-95. PubMed ID: 23341177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.
    Burnett-Hartman AN; Newcomb PA; Potter JD; Passarelli MN; Phipps AI; Wurscher MA; Grady WM; Zhu LC; Upton MP; Makar KW
    Cancer Res; 2013 May; 73(9):2863-72. PubMed ID: 23539450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype.
    Fang M; Ou J; Hutchinson L; Green MR
    Mol Cell; 2014 Sep; 55(6):904-915. PubMed ID: 25219500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia.
    Hua X; Newcomb PA; Chubak J; Malen RC; Ziebell R; Kamineni A; Zhu LC; Upton MP; Wurscher MA; Thomas SS; Newman H; Hardikar S; Burnett-Hartman AN
    Cancer Causes Control; 2020 Jul; 31(7):631-640. PubMed ID: 32358694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.